🔗 Permalink

Inventor profile of:

Matthew Duncton

City:

San Bruno, California

Country:

United States

Published Applications:

Last publication date:

2026-04-30

Top Assignees for applications by Matthew Duncton

The entities that hold a legal rights for patent applications filed by inventor Duncton Matthew:

Rigel Pharmaceuticals, Inc. 30 South San Francisco, CA United States
TERRAN BIOSCIENCES, INC. 3 NEW YORK, NY United States
Terran Biosciences Inc. 2 Miami Beach, FL United States
Rigel Pharmaceuticals, Inc. 1 Saouth San Francisco, CA United States
Deciduous Therapeutics, Inc. 1 San Francisco, CA United States
Rigl Pharmaceutical, Inc. 1 South San Francisco, CA United States
EVOTEC AG 1 Hamburg, Germany

Recent patent applications by Duncton Matthew

Matthew Duncton from San Bruno, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-30

US20260116873A1

Chemistry; metallurgy

APYRASE INHIBITORS

#2 | 2026-04-30

US20260116872A1

Chemistry; metallurgy

THIOPHENE BASED APYRASE INHIBITORS

#3 | 2025-12-18

US20250381206A1

Human necessities

INVARIANT NATURAL KILLER T-CELL ACTIVATORS

#4 | 2025-09-04

US20250275539A1

Human necessities

APYRASE INHIBITORS

#5 | 2025-09-04

US20250275537A1

Human necessities

CARBOXAMIDE APYRASE INHIBITORS

#6 | 2024-09-05

US20240294488A1

Chemistry; metallurgy

ISOTOPOLOGES, SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF

#7 | 2024-03-28

US20240101510A1

Chemistry; metallurgy

APYRASE INHIBITORS

#8 | 2024-03-28

US20240099300A1

Human necessities

SULFONAMIDE APYRASE INHIBITORS

#9 | 2024-02-01

US20240034718A1

Chemistry; metallurgy

Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amine

#10 | 2024-01-04

US20240002337A1

Chemistry; metallurgy

SALTS AND SOLID FORMS OF (R)-1-(5-METHOXY-1H-INDOL-1-YL)-N,N-DIMETHYLPROPAN-2-AMINE

#11 | 2023-09-07

US20230279017A1

Chemistry; metallurgy

Solid forms of tabernanthalog monofumarate salt for treating neurological disorders and/or psychiatric disorders

#12 | 2023-08-17

US20230257385A1

Chemistry; metallurgy

SALT AND SOLID FORMS OF TABERNANTHALOG

#13 | 2023-07-20

US20230227422A1

Chemistry; metallurgy

Phenethylamine compounds salts, polymorphic forms and methods of use thereof

#14 | 2023-06-29

US20230202998A1

Chemistry; metallurgy

PHENETHYLAMINE COMPOUNDS SALTS, POLYMORPHIC FORMS AND METHODS OF USE THEREOF

#15 | 2023-06-22

US20230192642A1

Chemistry; metallurgy

Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereof

#16 | 2023-06-15

US20230181521A1

Human necessities

ISOTOPICALLY ENRICHED ANALOGS OF 5,6-METHYLENEDIOXY-2-AMINOINDANE (MDAI)

#17 | 2023-05-25

US20230159544A1

Chemistry; metallurgy

AZEPINO-INDOLES FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS

#18 | 2023-05-25

US20230159456A1

Chemistry; metallurgy

N-SUBSTITUTED INDOLES

#19 | 2023-05-18

US20230151036A1

Chemistry; metallurgy

Psilocybin and O-acetylpsilocin, salts and solid state forms thereof

#20 | 2023-05-18

US20230150966A1

Chemistry; metallurgy

ISOTOPICALLY ENRICHED 3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE) AND STEREOISOMERS THEREOF

#21 | 2023-05-18

US20230150965A1

Chemistry; metallurgy

ISOTOPICALLY ENRICHED N-METHYL-1,3-BENZODIOXOLYLBUTANAMINE (MBDB) AND STEREOISOMERS THEREOF

#22 | 2023-05-18

US20230150936A1

Chemistry; metallurgy

ANALOGS OF N,N,N-TRIMETHYL-4-PHOSPHORYLOXYTRYPTAMINE

#23 | 2023-05-18

US20230150920A1

Chemistry; metallurgy

SALTS AND SOLID FORMS OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE

#24 | 2022-03-31

US20220098175A1

Chemistry; metallurgy

DIRECT AMPK ACTIVATORS

#25 | 2021-03-18

US20210078969A1

Chemistry; metallurgy

Nrf2 activating compounds and uses thereof

#26 | 2020-10-29

US20200339538A1

Chemistry; metallurgy

Nrf2 activating compounds and uses thereof

#27 | 2020-07-09

US20200216412A1

Chemistry; metallurgy

Nrf2 activating compounds and uses thereof

#28 | 2020-05-21

US20200155531A1

Human necessities

Fumarate analogs and uses thereof

#29 | 2019-02-28

US20190060310A1

Human necessities

Protein kinase C inhibitors and uses thereof

#30 | 2018-09-13

US20180258070A1

Chemistry; metallurgy

Nrf2 activating compounds and uses thereof

#31 | 2018-09-13

US20180258063A1

Chemistry; metallurgy

Nrf2 activating compounds and uses thereof

#32 | 2018-03-15

US20180071271A1

Human necessities

Fumarate analogs and uses thereof

#33 | 2018-02-22

US20180051006A1

Chemistry; metallurgy

Direct AMPK activators

#34 | 2018-02-01

US20180030050A1

Chemistry; metallurgy

Protein kinase C inhibitors and uses thereof

#35 | 2018-01-04

US20180002297A1

Chemistry; metallurgy

Tetrazolones as a carboxylic acid bioisosteres

#36 | 2017-12-21

US20170360786A1

Human necessities

Protein Kinase C Inhibitors and Uses Thereof

#37 | 2017-08-03

US20170217932A1

Chemistry; metallurgy

Nrf2 activating compounds and uses thereof

#38 | 2017-08-03

US20170217922A1

Chemistry; metallurgy

Nrf2 activating compounds and uses thereof

#39 | 2017-06-01

US20170152246A1

Chemistry; metallurgy

Protein kinase C inhibitors and uses thereof

#40 | 2017-05-11

US20170129862A1

Chemistry; metallurgy

Tetrazolones as a carboxylic acid bioisosteres

#41 | 2017-03-09

US20170065569A1

Human necessities

Fumarate analogs and uses thereof

#42 | 2016-09-08

US20160257681A1

Chemistry; metallurgy

Protein kinase C inhibitors and uses thereof

#43 | 2016-07-28

US20160213648A1

Human necessities

Tetrazolones as a carboxylic acid bioisosteres

#44 | 2016-03-03

US20160058760A1

Human necessities

Protein kinase C inhibitors and uses thereof

#45 | 2016-02-11

US20160039773A1

Chemistry; metallurgy

Fumarate analogs and uses thereof

#46 | 2015-10-29

US20150306100A1

Human necessities

Protein kinase C inhibitors and uses thereof

#47 | 2014-11-06

US20140329842A1

Chemistry; metallurgy

Protein kinase C inhibitors and uses thereof

#48 | 2014-10-02

US20140296557A1

Chemistry; metallurgy

Cyclopropyl MIDA boronate

#49 | 2014-09-18

US20140275055A1

Chemistry; metallurgy

Protein kinase C inhibitors and uses thereof

#50 | 2014-06-12

US20140163022A1

Chemistry; metallurgy

Protein kinase C inhibitors and uses thereof

#51 | 2013-12-12

US20130331585A1

Chemistry; metallurgy

Cyclopropyl PIDA boronate

#52 | 2013-12-12

US20130331374A1

Chemistry; metallurgy

Protein kinase C inhibitors and uses thereof

#53 | 2013-08-15

US20130210810A1

Human necessities

Protein kinase C inhibitors and uses thereof

#54 | 2013-02-21

US20130045973A1

Chemistry; metallurgy

AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME

#55 | 2012-06-07

US20120142915A1

Chemistry; metallurgy

Cyclopropyl MIDA boronate

#56 | 2012-01-26

US20120022092A1

Chemistry; metallurgy

Protein kinase C inhibitors and uses thereof

#57 | 2011-10-20

US20110257208A1

Chemistry; metallurgy

COMPOUNDS USEFUL AS FAAH MODULATORS AND USES THEREOF

#58 | 2011-06-02

US20110130415A1

Chemistry; metallurgy

PROTEIN KINASE C INHIBITORS AND USES THEREOF

#59 | 2011-02-03

US20110028465A1

Chemistry; metallurgy

Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

#60 | 2010-08-12

US20100204208A1

Human necessities

Protein kinase C inhibitors and uses thereof

InventorID:

102159 ⎘